Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Prellis Biologicsprellisbio.comPrellis Biologics integrates human biology with machine learning through its EXIS platform to discover next-generation therapeutics by using bioprinted lymph node organoids (LNOs) that recapitulate the human immune system and access the diverse human antibody repertoire in vitro. This platform delivers high hit rates on tough targets, generates large numbers of initial leads from a fully human antibody repertoire, and lowers immunogenicity risk, accelerating progress toward clinic-ready medicines. AI-guided screening and optimization, combined with wet-lab validation and strategic partnerships, accelerate discovery of novel antibody therapeutics.
Parse Score
Sources
patientanalog.com shapes more of what AI says about Prellis Biologics than any other source, at 67% of its citations.
media.market.us
